Molecular basis of calcium-sensitizing and desensitizing mutations of the human cardiac troponin C regulatory domain:

Peter Michael Kekenes-Huskey1, Steffen Lindert, James Andrew McCammon

  • 1Department of Pharmacology, Center for Theoretical Biological Physics, National Computational Biomedical Resource and Howard Hughes Medical Institute, University of California San Diego, La Jolla, California, United States of America. pkekeneshuskey@ucsd.edu

Insights

Mutations in cardiac Troponin C (TnC) alter calcium sensitivity and myocyte contraction. Molecular dynamics simulations reveal distinct structural changes in gain-of-function (GOF) and loss-of-function (LOF) TnC mutants, explaining altered calcium binding and guiding inotropic drug development.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Biophysics

Background:

  • Cardiac Troponin C (TnC) regulates myocyte contraction by binding calcium (Ca²⁺) and interacting with Troponin I.
  • Mutations in the TnC N-terminal regulatory domain can alter Ca²⁺ sensitivity and force generation.
  • Understanding these structural changes is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the structural basis of altered Ca²⁺ sensitivity in engineered TnC variants using molecular dynamics (MD) simulations.
  • To differentiate the structural dynamics between gain-of-function (GOF) and loss-of-function (LOF) TnC mutants.
  • To provide a structural rationale for observed binding trends and guide the development of inotropic drugs.

Main Methods:

  • Molecular dynamics (MD) simulations of engineered TnC variants with altered Ca²⁺ sensitivity.
  • Analysis of Ca²⁺ binding site II conformation in both Ca²⁺-free (apo) and Ca²⁺-bound (holo) states.
  • Examination of positional correlations between helices in different TnC mutant conformations.

Main Results:

  • GOF mutants (V44Q, L48Q) exhibited a stable Ca²⁺-binding site II structure in the apo state, resembling the holo state.
  • LOF mutants (E40A, V79Q) showed a labile apo site II conformation, differing significantly from the holo state.
  • GOF holo mutants displayed unique inter-helical positional correlations absent in LOF mutants, potentially impacting Ca²⁺ affinity or TnI interaction.

Conclusions:

  • The structural stability of the Ca²⁺-binding site in apo-TnC correlates with Ca²⁺ affinity and functional outcomes (GOF vs. LOF).
  • Observed inter-helical dynamics in GOF mutants may directly influence Ca²⁺ binding or indirectly affect Troponin I association.
  • These findings offer a structural framework for understanding TnC mutations and developing novel inotropic agents targeting TnC.